View in EDS HTML Full Text PDF Full Text

Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.

Saved in:
Bibliographic Details
Title: Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.
Authors: Molica, Stefano1 (AUTHOR), Scalzulli, Potito Rosario2 (AUTHOR), Scarfò, Lydia3,4 (AUTHOR), Minoia, Carla4,5 (AUTHOR), Murru, Roberta5,6 (AUTHOR), Sportoletti, Paolo6,7 (AUTHOR), Albano, Francesco7,8 (AUTHOR), Di Renzo, Nicola8,9 (AUTHOR), Sanna, Alessandro9,10 (AUTHOR), Laurenti, Luca10,11 (AUTHOR), Massaia, Massimo11,12,13 (AUTHOR), Cassin, Ramona12,14 (AUTHOR), Coscia, Marta13,15,16 (AUTHOR), Patti, Caterina14,17 (AUTHOR), Pennese, Elsa15,18 (AUTHOR), Tafuri, Agostino16,19 (AUTHOR), Chiarenza, Annalisa17,20 (AUTHOR), Galieni, Piero18,21 (AUTHOR), Perbellini, Omar19,22,23 (AUTHOR), Selleri, Carmine20,24 (AUTHOR)
Source: Cancers. Mar2026, Vol. 18 Issue 6, p1000. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers18061000